Efficacy of Ultrasound Guided Erector Spinae Plane Block Versus Ultrasound Guided Serratus Anterior Plane Block for Postoperative Pain Control Following Video-assisted Thoracoscopic Surgeries (VATS): Randomized Control Trial
1 other identifier
interventional
50
1 country
1
Brief Summary
The aim of the study is to compare the analgesic efficacy of Erector spinae plane block versus Serratus anterior plane block in patients undergoing video-assisted thoracoscopic surgeries.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2025
CompletedFirst Submitted
Initial submission to the registry
January 14, 2026
CompletedFirst Posted
Study publicly available on registry
January 22, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 30, 2027
January 22, 2026
January 1, 2026
2.1 years
January 14, 2026
January 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Visual analogue scale for Assessing postoperative pain control
Assessing The difference in postoperative pain control between both groups as determined by assessing the visual analogue scale
after ICU admission at 2, 4, 8, 16, 24 hours post operative.
Study Arms (2)
Erectror Spinae Plane Block
ACTIVE COMPARATORUltrasound Guided block using 20 mL of 0.25% bupivacaine.
Serratus Anterior Plane Block
ACTIVE COMPARATORUltrasound Guided block using 20 mL of 0.25% bupivacaine.
Interventions
Ultrasound Guided Erector Spinae Plane block using 20 mL of 0.25% bupivacaine.
Ultrasound Guided Serratus Anterior Plane Block using 20 mL of 0.25% bupivacaine.
Eligibility Criteria
You may qualify if:
- Patients with American Society of Anesthesiology physical status ASA I, II and III.
- Patients aged between 25 and 70 years.
- patients undergoing video-assisted thoracoscopic surgeries (VATS), including pleurectomy, bullectomy, sympathectomy, esophagectomy, decortication, lobectomy, and pneumonectomy.
You may not qualify if:
- Patients below age of 25 or above age of 70.
- Patient refusal.
- Allergy to local anesthetic drugs.
- Bleeding or coagulation disorder.
- Psychiatric disorders.
- Infection at the needle entry site.
- Renal impairment (creatinine \>1.5 ).
- Hepatic impairment (Child B or C).
- Patients with known Cortisol related diseases such as Cushing's Syndrome or Addison's Disease.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ain-Shams University Hospitals
Cairo, Abbassia-Egypt, Egypt
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 14, 2026
First Posted
January 22, 2026
Study Start
December 1, 2025
Primary Completion (Estimated)
December 30, 2027
Study Completion (Estimated)
December 30, 2027
Last Updated
January 22, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share